ATP |
adenosine triphosphate |
BDNF |
brain-derived neurotrophic factor |
bFGF |
basic fibroblast growth factor |
CCL5/RANTES |
CC-chemokine ligand 5 |
CD40L |
CD40 ligand |
CFU |
colony-forming units |
cMYC |
myc proto-oncogene protein |
DENV |
dengue virus |
DNA |
deoxyribonucleic acid |
ECFCs |
endothelial colony-forming progenitor cells |
EGF |
epidermal growth factor |
EIA/ECLIA |
enzyme- or electro-chemiluminiscence immunoassays |
ELISA |
enzyme-linked immunosorbent assay |
EMA |
European Medicine Agency |
EU |
endotoxin unit |
FBS |
fetal bovine serum |
FDA |
U.S. Food and Drug Administration |
GF |
growth factor |
GMP |
good manufacturing practice |
HAV |
hepatitis A virus |
HBV |
hepatitis B virus |
HCV |
hepatitis C virus |
HEV |
hepatitis E virus |
HGF |
hepatocyte growth factor |
HIV-1/2 |
human immunodeficiency virus type 1 or type 2 |
HPL |
human platelet lysate |
IAT |
indirect antiglobulin test |
ICAM-1 |
intercellular adhesion molecule 1 |
IGF-1 |
insulin-like growth factor 1 |
IU |
international units |
KLF4 |
Kruppel-like factor 4 |
LAL |
limulus amebocyte lysate |
MPCs |
myoprogenitor cells |
MSCs |
mesenchymal stromal cells |
NAT |
nucleic acid amplification technology |
PB19 |
parvovirus B19 |
PCR |
polymerase chain reaction |
PCR-SSP |
polymerase chain reaction-single specific primer |
PDGF |
platelet-derived growth factor |
PR |
pathogen reduction |
PRP |
platelet rich plasma |
rh |
recombinant human |
RNA |
ribonucleic acid |
S/D |
solvent/detergent |
SOX2 |
sex-determining region Y (SRY)- box 2 |
SPC |
statistical process control |
TGF-β |
transforming growth factor β |
U.S. |
United States |
USP |
U.S. Pharmacopeia |
UV |
ultraviolet |
VCAM-1 |
vascular cell adhesion molecule-1 |
VEGF |
vascular endothelial growth factor |
WNV |
West Nile virus |
ZIKV |
Zika virus |